Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
iCAD, Inc. is a leader in AI-powered cancer detection, specializing in breast health solutions. Its flagship product, the ProFound Breast Health Suite, enhances early cancer detection and risk assessment through advanced imaging technology. With a significant market opportunity in the growing breast cancer screening sector, iCAD targets healthcare providers globally. The company is transitioning to a subscription-based model and expanding partnerships to improve access and streamline workflows, enhancing patient care.
This description was generated via AI from an annual report. Updated almost 2 years ago.